Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.64 |
| ▸ | RAB9A | P51151 | 4/20 | 0.64 |
| ▸ | GAA | P10253 | 3/20 | 0.64 |
| ▸ | NPC1 | O15118 | 3/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | CA1 | P00915 | 3/20 | 0.58 |
| ▸ | CA2 | P00918 | 3/20 | 0.58 |
| ▸ | CA7 | P43166 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31565002 | 0.91 | MAPT (0.54) | MAPTRAB9AGAANPC1MAPK1 | |
| SCHEMBL8359254 | 0.80 | MAPT (0.58) | MAPTRAB9AGAANPC1MAPK1 | |
| Bromide SCHEMBL28373773 | 0.78 | MAPT (0.56) | MAPTRAB9AGAANPC1MAPK1 | |
| Hydrochloric Acid SCHEMBL28375387 | 0.78 | MAPT (0.56) | MAPTRAB9AGAANPC1MAPK1 | |
| Water SCHEMBL10563582 | 0.78 | GAA (0.56) | MAPTRAB9AGAANPC1MAPK1 | |
| SCHEMBL851498 | 0.78 | RAB9A (0.70) | MAPTRAB9AGAANPC1MAPK1 | |
| SCHEMBL1459772 | 0.78 | MAPT (1.00) | MAPTRAB9AGAANPC1MAPK1 | |
| SCHEMBL39057 | 0.78 | MAPT (1.00) | MAPTRAB9AGAANPC1MAPK1 | |
| SCHEMBL23270081 | 0.77 | CYP1A2 (0.55) | MAPTRAB9AGAANPC1MAPK1 | |
| 1,4-Dimethoxybenzene SCHEMBL8489 | 0.76 | CA1 (1.00) | MAPTRAB9AGAANPC1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4914213-A | Indole derivatives and process for producing the same | FUJI PHOTO FILM CO., LTD. (JP) | 1990-04-03 | — | — | US | claimed |
| US-4707553-A | Indole derivatives and process for producing the same | FUJI PHOTO FILM CO., LTD. (JP) | 1987-11-17 | — | — | US | claimed |
| US-4159264-A | Automatic control of azo coupling processes in the manufacture of azo pigments | CIBA-GEIGY CORPORATION (US) | 1979-06-26 | — | — | US | claimed |
| EP-4680602-A1 | HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS | Miralinc Pharma, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024192237-A1 | HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS | MIRALINC PHARMA, INC. (US) | 2024-09-19 | — | — | WO | disclosed |
| US-20230159476-A1 | PROCESS FOR THE SYNTHESIS OF COMPOUNDS WHICH ABSORB ULTRAVIOLET RADIATION IN FLOW CONDITIONS AND FORMULATIONS COMPRISING SAME | ELIKIMIA INC (CA) | 2023-05-25 | — | — | US | disclosed |
| US-20230159476-A1 | PROCESS FOR THE SYNTHESIS OF COMPOUNDS WHICH ABSORB ULTRAVIOLET RADIATION IN FLOW CONDITIONS AND FORMULATIONS COMPRISING SAME | ELIKIMIA INC (CA) | 2023-05-25 | — | — | US | disclosed |
| WO-2023279205-A1 | ULTRAVIOLET AND VISIBLE RADIATION ABSORBING COMPOUNDS | elkimia inc. (CA) | 2023-01-12 | — | — | WO | disclosed |
| CN-105294732-B | Conformationally constrained, fully synthetic macrocyclic compounds | 波利弗尔股份公司 | 2018-09-25 | — | — | CN | disclosed |
| US-9353100-B2 | Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections | IDENIX PHARMACEUTICALS LLC (US) | 2016-05-31 | — | — | US | disclosed |
| EP-2461811-B1 | MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV | IDENIX PHARMACEUTICALS LLC (US) | 2016-04-20 | — | — | EP | disclosed |
| US-4224027-A | Process for the production of water-insoluble azo dyestuffs on the fiber with polyphosphate | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-09-23 | — | — | US | disclosed |
| US-4183727-A | Process for the production of water-insoluble azo dyestuffs on the fiber | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-01-15 | — | — | US | disclosed |
| US-4159264-A | Automatic control of azo coupling processes in the manufacture of azo pigments | CIBA-GEIGY CORPORATION (US) | 1979-06-26 | — | — | US | disclosed |
| US-4115055-A | Mixture of water-insoluble monoazo dyestuffs for coloring textile materials consisting at least partly of linear, aromatic polyesters | ROHNER AG PRATTELN (CH) | 1978-09-19 | — | — | US | disclosed |
| US-4082503-A | PROCESS FOR THE PRODUCTION OF WATER-INSOLUBLE AZO DYESTUFFS ON THE FIBER | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-04-04 | — | — | US | disclosed |
| US-4035144-A | Dyeing preparations containing boric acid for preparing water-insoluble azo dyestuffs on fiber | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-07-12 | — | — | US | disclosed |
| US-3960926-A | Process for preparing azasulfonium halide salts | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1976-06-01 | — | — | US | disclosed |
| US-3954797-A | Process for preparing azasulfonium halide salts | CHROMALLOY AMERICAN CORPORATION (US) | 1976-05-04 | — | — | US | disclosed |
| US-3947515-A | Process for the preparation of pure, aromatic o-hydroxy-carboxylic acid aryl amides | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159476-A1 | PROCESS FOR THE SYNTHESIS OF COMPOUNDS WHICH ABSORB ULTRAVIOLET RADIATION IN FLOW CONDITIONS AND FORMULATIONS COMPRISING SAME | ERCC4, XPA, ERCC1 | MAPT 358/4885RAB9A 1286/4885GAA 307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.